PT  - JOURNAL ARTICLE
AU  - Halatoko, Wemboo Afiwa
AU  - Konu, Yao Rodion
AU  - Gbeasor-Komlanvi, Fifonsi Adjidossi
AU  - Sadio, Arnold Junior
AU  - Tchankoni, Martin Kouame
AU  - Komlanvi, Koffi Segbeaya
AU  - Salou, Mounerou
AU  - Dorkenoo, Ameyo Monique
AU  - Maman, Issaka
AU  - Agbobli, Amétépé
AU  - Wateba, Majesté Ihou
AU  - Adjoh, Komi Séraphin
AU  - Akue, Edem Goeh
AU  - Kao, Yem-bla
AU  - Kpeto, Innocent
AU  - Pana, Paul
AU  - Kinde-Sossou, Rebecca
AU  - Tamekloe, Agbeko
AU  - Nayo-Apetsianyi, Josée
AU  - Assane, Simon-Pierre Hamadi
AU  - Prince-David, Mireille
AU  - Awoussi, Sossinou Marcel
AU  - Djibril, Mohaman
AU  - Mijiyawa, Moustafa
AU  - Dagnra, Anoumou Claver
AU  - Ekouevi, Didier Koumavi
TI  - Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
AID  - 10.1101/2020.08.07.20163840
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.07.20163840
4099  - http://medrxiv.org/content/early/2020/08/07/2020.08.07.20163840.short
4100  - http://medrxiv.org/content/early/2020/08/07/2020.08.07.20163840.full
AB  - Objective This survey aims at estimating the prevalence of SARS-CoV-2 in high risk populations in Lomé.Methods From April 23rd to May 8th 2020, we recruited a random sample of participants from five sectors: healthcare, air transport, police, road transport and informal. We collected oropharyngeal swab for direct detection through real time reverse transcription polymerase chain reaction (rRT-PCR), and blood for antibodies detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests.Results A total of 955 participants with a median age of 36 (IQR 32-43) were included and 71.6% (n=684) were men. Around 22.1% (n=212) were from the air transport sector, 20.5% (n=196) in the police, and 38.7% (n=370) in the health sector. Seven participants (0.7%, 95% CI: 0.3-1.6%) had a positive rRT-PCR at the time of recruitment and nine (0.9%, 95% CI: 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n=15), 95% CI: 0.9-2.6%.Conclusion The prevalence of the SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Bioethics Committee for Health Research from the Togo Ministry of Health (No. 004/2020/CBRS)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available on request by sending an email to authors.95% CI95% confidence intervalIQRinterquartile range